Silverback Therapeutics shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Silverback Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Silverback Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Silverback Therapeutics by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $714k | 70k | 10.22 |
| 2023-12-31 | $462k | 84k | 5.48 |
| 2023-09-30 | $317k | 84k | 3.78 |
| 2023-06-30 | $515k | 77k | 6.70 |
| 2023-03-31 | $99k | 15k | 6.51 |
| 2022-12-31 | $130k | 15k | 8.53 |
| 2022-03-31 | $206k | 59k | 3.52 |
| 2021-12-31 | $401k | 60k | 6.68 |
| 2021-09-30 | $566k | 57k | 9.99 |
| 2021-06-30 | $1.2M | 40k | 30.93 |
| 2021-03-31 | $1.5M | 35k | 43.53 |